European Lung Cancer Congress 2024
The European Lung Cancer Congress 2024, held March 20-23, in Prague, features information on prevention, screening and early diagnosis of thoracic tumors; recent developments on molecular diagnosis and therapeutic classes for lung cancer; and more. The congress is a collaborative effort of multidisciplinary societies representing thoracic oncology specialists who are “working together to advance science, disseminate education and improve the practice of lung cancer specialists worldwide,” according to organizers.
Amivantamab plus chemotherapy “significantly prolonged time to symptomatic progression” compared with chemotherapy alone.
There was a significant association between the intake of certain fatty acids and overall survival outcomes.
Certain features were over-represented among a cohort of young adults with lung cancer.
Researchers evaluated the use of ctDNA next-generation sequencing panels that included NTRK gene fusions.
Advertisement
Advertisement
